Because abnormal Smo activation contributes to many types of human cancer, the finding that CK1γ is a conserved positive regulator of Hh signaling raises an interesting possibility that interfering with the interaction between CK1γ and Smo may serve as a strategy for cancer treatment. Here, SMO is linked to cancer.